查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750817

北美和欧洲药物稳定性服务市场规模、份额和趋势分析报告：按服务、分子、国家和细分市场预测，2025 年至 2030 年

North America And Europe Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

北美和欧洲药品稳定储存服务市场的成长和趋势：

预计到 2030 年北美和欧洲医药仓储服务市场规模将达到 19.2 亿美元。

根据 Grand View Research, Inc. 的最新报告，预计预测期内的复合年增长率为 6.4%。严格的监管要求、不断增加的研发投资以及临床试验的全球化是推动市场成长的一些关键因素。

生物相似药需求的不断增长预计将推动市场发展。近年来，生物相似药的核准率显着提高。根据安进公司2020年发布的《生物相似药趋势报告》，美国核准的生物相似药数量较前一年增加了65%。截至2023年，美国已批准41种生物相似药，欧盟已核准超过70种生物相似药。生物相似药核准的扩大可能会对市场产生正面影响。

此外，这些地区日益转向个人化医疗，因此需要根据个人化治疗特征量身订做稳定性测试，以确保针对特定患者的治疗方案有效。自动化、进阶数据分析、即时监控技术整合、稳定性测试流程的简化以及更快的决策速度等技术进步也正在改变产业格局。这些进步提高了业务效率，并提供了对产品行为的即时洞察，进一步推动了市场成长。

此外，北美和欧洲的製药业受益于高度发展的基础设施，其拥有先进的稳定性测试和储存设施，能够满足现代药品（包括温度敏感型产品）的复杂需求。此外，新药研发线的不断增长，尤其是那些具有特殊储存需求和较短保质期的药物，例如生技药品和特种药物，也推动了对先进稳定性储存解决方案的需求。

北美和欧洲药品稳定性服务市场报告重点：

  • 稳定性测试部分在服务部分占据主导地位，2024 年的收入份额最大，为 73.8%。生物製药和个人化医疗需求的快速成长正在推动药物稳定性服务的进步。
  • 由于发展中地区对学名药和生物相似药的关注度不断提高，预计预测期内储存领域的复合年增长率将达到 5.8%。
  • 小分子药物领域将占据市场主导地位，到 2024 年将占据 79.4% 的最大收入份额。预测、基于结构的设计、成像、自动化、人工智慧和机器学习的最新进展是提高小分子先导药物最适化速度和成功率的关键驱动力。
  • 由于蛋白质、核酸、碳水化合物、生物细胞和组织等大分子的应用日益广泛，预计聚合物领域将在 2025 年至 2030 年间以显着的复合年增长率增长。
  • 北美在药品稳定性服务市场占据主导地位，因为包括生技药品和个人化药物在内的复杂药品数量不断增加，需要专门的稳定性测试和受控储存解决方案，从而刺激了市场扩张。
  • 预计未来几年欧洲也将占据相当大的市场占有率。英国正专注于药物研发。随着企业投资开发新药并进行临床试验，对支援这些活动的稳定性测试和储存服务的需求日益增长。

目录

第一章调查方法与范围

第二章执行摘要

3. 北美和欧洲药物稳定性服务市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美及欧洲医药稳定储存服务市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析

第四章北美和欧洲药品稳定性服务市场分析（按服务）

  • 服务细分仪表板
  • 医药稳定仓储服务市场：服务波动分析
  • 北美及欧洲医药稳定储存服务市场规模及趋势分析（按服务，2018-2030 年）
  • 稳定性测试
  • 贮存

5. 北美和欧洲药物稳定性服务市场-分子分析

  • 分子细分仪表板
  • 药品稳定储存服务市场：依分子波动分析
  • 北美及欧洲医药稳定储存服务市场规模及趋势分析（按分子，2018-2030 年）
  • 小分子
  • 大分子

6. 北美和欧洲医药稳定储存服务市场：国家分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 北美及欧洲药品仓储服务市场（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • Key Company Heat Map Analysis, 2024
  • 公司简介
    • Eurofins Scientific
    • Intertek Group plc
    • Lucideon Limited
    • Element Materials Technology
    • Q1 Scientific
    • Reading Scientific Services Ltd.
    • Catalent, Inc.
    • Quotient Sciences
    • Recipharm AB
    • Almac Group
    • Alcami Corporation
    • BioLife Solutions, Inc.
    • Sampled（Roylance Stability Storage Limited）
    • Precision Stability Storage
    • Broughton
Product Code: GVR-4-68040-123-7

North America And Europe Pharmaceutical Stability & Storage Services Market Growth & Trends:

The North America and Europe pharmaceutical stability & storage services market is anticipated to reach USD 1.92 billion by 2030. It is anticipated to expand at a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. Stringent regulatory requirements, increasing R&D investments, and globalization of clinical trials are some of the major factors driving market growth.

The rising demand for biosimilars is expected to drive market advancement. In recent years, the approval rate for biosimilars has significantly improved. As per the Amgen Biosimilars Trend Report published in 2020, the number of biosimilar approvals in the U.S. increased by 65% since the preceding year. As of 2023, 41 biosimilars were approved in the U.S., and over 70 were approved in the EU. The growing approval of biosimilars is likely to impact the market positively.

In addition, the shift toward personalized medicine in these regions necessitates stability testing tailored to the distinct features of individualized treatments, ensuring that patient-specific therapies remain effective. Technological innovations have also transformed the landscape, integrating automation, advanced data analytics, and real-time monitoring technologies, streamlining stability testing processes, and accelerating decision-making. These advancements enhance operational effectiveness and provide immediate insights into product behavior, further propelling market growth.

Furthermore, the pharmaceutical industries in North America and Europe benefit from highly developed infrastructure equipped with state-of-the-art facilities for stability testing and storage, supporting the complex requirements of modern pharmaceuticals, including temperature-sensitive products. The increasing pipeline of new drugs, especially biologics and specialty medicines with unique storage needs and shorter shelf lives, also drives demand for advanced stability and storage solutions.

North America And Europe Pharmaceutical Stability & Storage Services Market Report Highlights:

  • The stability testing segment dominated the service segment. It held the largest revenue share of 73.8% in 2024. The rapid growth in the demand for biopharmaceuticals and personalized medicines is driving advancements in pharmaceutical stability services
  • The storage segment is expected to grow at a CAGR of 5.8% over the forecast period, owing to the increasing focus on generics and biosimilars in developing regions.
  • The small molecules segment dominated the market, with the largest revenue share of 79.4% in 2024. Recent advances in forecasting, structure-based design, imaging, automation, artificial intelligence, and machine learning have become critical facilitators for increasing small molecules lead optimization's pace and success rates
  • The large molecules segment is expected to grow at a significant CAGR from 2025 to 2030. This is due to the increasing adoption of large molecules such as proteins, nucleic acids, carbohydrates, living cells, and tissues.
  • North America dominated the pharmaceutical stability & storage services market. It held the largest revenue share in 2024, driven by the growing pipeline of complex drugs, including biologics and personalized medicines, necessitating specialized stability testing and controlled storage solutions, fueling market expansion.
  • Europe is also expected to account for a significant market share in the coming years. The UK has a strong emphasis on R&D in the pharmaceutical sector. As companies invest in developing new drugs and conducting clinical trials, there is an increased demand for stability testing and storage services to support these activities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Molecule
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service Outlook
    • 2.2.2. Molecule Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe Pharmaceutical Stability and Storage Services Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. North America and Europe Pharmaceutical Stability and Storage Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. North America and Europe Pharmaceutical Stability and Storage Services Market: Service Business Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Pharmaceutical Stability and Storage Services Market: Service Movement Analysis
  • 4.3. North America and Europe Pharmaceutical Stability and Storage Services Market Size & Trend Analysis, By Service, 2018 to 2030 (USD Million)
  • 4.4. Stability Testing
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Drug Substance
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Stability Indicating Method Validation
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Accelerated Stability Testing
      • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Photo Stability Testing
      • 4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Other Stability Testing Methods
      • 4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Storage
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Cold
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Non-Cold
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Business Analysis

  • 5.1. Molecule Segment Dashboard
  • 5.2. Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
  • 5.3. North America and Europe Pharmaceutical Stability and Storage Services Market Size & Trend Analysis, By Molecule, 2018 to 2030 (USD Million)
  • 5.4. Small Molecule
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Research Products
      • 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Commercial Products
      • 5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Large Molecule
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Research Products
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Commercial Products
      • 5.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. North America and Europe Pharmaceutical Stability and Storage Services Market: Country Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America and Europe Pharmaceutical Stability and Storage Services Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Germany
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Eurofins Scientific
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Intertek Group plc
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Lucideon Limited
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Element Materials Technology
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Q1 Scientific
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Reading Scientific Services Ltd.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Catalent, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Quotient Sciences
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Recipharm AB
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Almac Group
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Alcami Corporation
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. BioLife Solutions, Inc.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Sampled (Roylance Stability Storage Limited)
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Precision Stability Storage
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Broughton
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 North America and Europe Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 3 North America and Europe Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 4 North America and Europe Pharmaceutical Stability and Storage Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Pharmaceutical Stability and Storage Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 10 Canada Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 12 Mexico Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 14 Europe Pharmaceutical Stability and Storage Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 17 Germany Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 18 Germany Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 20 UK Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 21 France Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 22 France Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 23 Italy Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 24 Italy Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 25 Spain Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 26 Spain Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 27 Denmark Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 28 Denmark Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 29 Sweden Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 30 Sweden Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 31 Norway Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 32 Norway Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 North America and Europe Pharmaceutical Stability and Storage Services Market: Market Outlook
  • Fig. 10 North America and Europe Pharmaceutical Stability and Storage Services Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 North America and Europe Pharmaceutical Stability and Storage Services Market Driver Impact
  • Fig. 16 North America and Europe Pharmaceutical Stability and Storage Services Market Restraint Impact
  • Fig. 17 North America and Europe Pharmaceutical Stability and Storage Services Market Strategic Initiatives Analysis
  • Fig. 18 North America and Europe Pharmaceutical Stability and Storage Services Market: Service Movement Analysis
  • Fig. 19 North America and Europe Pharmaceutical Stability and Storage Services Market: Service Outlook and Key Takeaways
  • Fig. 20 Stability Testing Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Storage Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
  • Fig. 23 North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Outlook and Key Takeaways
  • Fig. 24 Small Molecule Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 Large Molecule Market Estimates and Forecasts, 2018 - 2030
  • Fig. 26 North America and Europe Pharmaceutical Stability and Storage Services Market: Regional Outlook and Key Takeaways
  • Fig. 27 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 30 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 31 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Norway Market Estimates and Forecasts, 2018 - 2030